$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000155837024005902 Filed on April 26, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$759.9K	$4.848M	$6.995M
YoY Change	15.53%	5966.1%	9.58%
Cost Of Revenue	$837.9K	$1.197M	$2.737M
YoY Change	118.39%	3029.03%	-57.24%
Gross Profit	-$77.99K	$3.651M	$4.258M
YoY Change	-128.46%	8660.77%	-23954.78%
Gross Profit Margin	-10.26%	75.32%	60.87%
Selling, General & Admin	$5.014M	$6.567M	$26.17M
YoY Change	-32.19%	-10.65%	27.47%
% of Gross Profit		179.85%	614.64%
Research & Development	$3.607M	$3.520M	$20.12M
YoY Change	-37.09%	-55.67%	-14.24%
% of Gross Profit		96.39%	472.54%
Depreciation & Amortization	$1.300M	$1.804M	$6.474M
YoY Change	18.18%	21.09%	206.11%
% of Gross Profit		49.41%	152.05%
Operating Expenses	$8.620M	$10.09M	$46.29M
YoY Change	50.36%	-35.11%	97.3%
Operating Profit	-$8.698M	-$6.435M	-$42.03M
YoY Change	-39.24%	-58.49%	-8.0%
Interest Expense	-$240.2K	-$296.0K	-$776.8K
YoY Change	10.69%	-190.88%	10.48%
% of Operating Profit
Other Income/Expense, Net	-$585.4K	$224.3K	-$301.4K
YoY Change	169.78%	-206.64%	-79.39%
Pretax Income	-$9.284M	-$6.507M	-$42.33M
YoY Change	-36.12%	-57.71%	-10.22%
Income Tax	$0.00	$0.00	-$571.1K
% Of Pretax Income
Net Earnings	-$8.875M	-$5.408M	-$45.22M
YoY Change	-36.12%	-55.49%	4.1%
Net Earnings / Revenue	-1167.83%	-111.55%	-646.44%
Basic Earnings Per Share	-$26.98		-$1.74
Diluted Earnings Per Share	-$26.98	-$0.20	-$1.74
COMMON SHARES
Basic Shares Outstanding	36.03M	26.08M	26.05M
Diluted Shares Outstanding	329.0K		26.05M

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$2.391M	$2.391M
YoY Change		-94.6%	-94.6%
Cash & Equivalents	$1.472M	$184.9K	$184.9K
Short-Term Investments		$2.207M	$2.207M
Other Short-Term Assets		$696.9K	$696.9K
YoY Change		-80.51%	-80.51%
Inventory	$70.83K	$909.2K	$909.2K
Prepaid Expenses
Receivables	$1.320M	$375.2K	$495.4K
Other Receivables		$268.0K	$268.0K
Total Short-Term Assets	$3.455M	$4.761M	$4.761M
YoY Change	-84.84%	-90.49%	-90.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.24M	$17.59M	$44.10M
YoY Change	-20.26%	-14.13%	5.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$454.3K	$454.3K
YoY Change		-18.41%	-18.41%
Total Long-Term Assets	$43.23M	$46.28M	$46.28M
YoY Change	-24.68%	-14.84%	-14.84%
TOTAL ASSETS
Total Short-Term Assets	$3.455M	$4.761M	$4.761M
Total Long-Term Assets	$43.23M	$46.28M	$46.28M
Total Assets	$46.69M	$51.04M	$51.04M
YoY Change	-41.77%	-51.11%	-51.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.797M	$4.110M	$4.110M
YoY Change	63.51%	-7.1%	-7.1%
Accrued Expenses	$2.735M	$2.202M	$2.726M
YoY Change	-21.38%	-48.82%	-26.32%
Deferred Revenue	$2.197M	$2.359M
YoY Change	-18.68%	48.78%
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due		$904.7K	$904.7K
YoY Change		200.51%	200.51%
Total Short-Term Liabilities	$10.82M	$10.10M	$10.10M
YoY Change	-29.46%	-44.0%	-44.0%
LONG-TERM LIABILITIES
Long-Term Debt		$9.016M	$9.016M
YoY Change		63.33%	63.33%
Other Long-Term Liabilities		$3.627M	$3.627M
YoY Change		-56.84%	-56.84%
Total Long-Term Liabilities		$12.64M	$12.64M
YoY Change		-9.19%	-9.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.82M	$10.10M	$10.10M
Total Long-Term Liabilities		$12.64M	$12.64M
Total Liabilities	$24.83M	$22.74M	$19.64M
YoY Change	-25.03%	-28.84%	-35.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$267.7M	-$254.4M
YoY Change	13.53%	21.61%
Common Stock	$99.00	$5.244K
YoY Change	-98.1%	2.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$25.61M	$31.40M	$31.40M
YoY Change
Total Liabilities & Shareholders Equity	$46.69M	$51.04M	$51.04M
YoY Change	-41.77%	-51.11%	-51.11%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$8.875M	-$5.408M	-$45.22M
YoY Change	-36.12%	-55.49%	4.1%
Depreciation, Depletion And Amortization	$1.300M	$1.804M	$6.474M
YoY Change	18.18%	21.09%	206.11%
Cash From Operating Activities		-$1.083M	-$31.53M
YoY Change		-86.2%	453.17%
INVESTING ACTIVITIES
Capital Expenditures		$135.6K	$1.986M
YoY Change		-83.99%	-90.13%
Acquisitions
YoY Change
Other Investing Activities		$2.232M	$34.22M
YoY Change		-72.83%	10.01%
Cash From Investing Activities		$2.097M	$32.24M
YoY Change		-71.55%	193.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$65.62K
YoY Change			9.94%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-6.202M	-8.952M
YoY Change		30.26%	82.44%
NET CHANGE
Cash From Operating Activities		-1.083M	-31.53M
Cash From Investing Activities		2.097M	32.24M
Cash From Financing Activities		-6.202M	-8.952M
Net Change In Cash		-5.188M	-8.250M
YoY Change		-0.88%	-2267.11%
FREE CASH FLOW
Cash From Operating Activities		-$1.083M	-$31.53M
Capital Expenditures		$135.6K	$1.986M
Free Cash Flow		-$1.218M	-$33.52M
YoY Change		-85.98%	29.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2844103
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	627 Davis Drive, Suite 300
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6438931
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25661488
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26219461
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25661488
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26219461
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.63
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	9052
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P11Y2M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P13Y3M18D
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35994
CY2023	dei	Entity Registrant Name EntityRegistrantName	Scorpius Holdings, Inc.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Morrisville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27560
CY2023	dei	City Area Code CityAreaCode	919
CY2023	dei	Local Phone Number LocalPhoneNumber	240-7133
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0002 par value per share
CY2023	dei	Trading Symbol TradingSymbol	SCPX
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	16554383
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36031964
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	BDO USA, P.C.
CY2023	dei	Auditor Location AuditorLocation	Raleigh, NC
CY2023	dei	Auditor Firm AuditorFirmId	243
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	184925
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3191714
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	2206555
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	35837309
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	375192
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81456
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	1524522
CY2023Q4	nhwk	Disposal Group Including Discontinued Operation Contingent Consideration Current DisposalGroupIncludingDiscontinuedOperationContingentConsiderationCurrent	268000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	817029
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1491123
CY2023Q4	us-gaap	Inventory Net InventoryNet	909158
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	7928136
CY2023Q4	us-gaap	Assets Current AssetsCurrent	4760859
CY2022Q4	us-gaap	Assets Current AssetsCurrent	50054260
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17587337
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20438521
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6041439
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5866261
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	20473742
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	15329075
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	203135
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	260011
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	251115
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	270461
CY2023Q4	nhwk	Disposal Group Including Discontinued Operation Earn Out Consideration Upon Achievement Of Certain Financial Goals DisposalGroupIncludingDiscontinuedOperationEarnOutConsiderationUponAchievementOfCertainFinancialGoals	1720000
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	12178323
CY2023Q4	us-gaap	Assets Assets	51037627
CY2022Q4	us-gaap	Assets Assets	104396912
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4109947
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4213732
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2359441
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1585808
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	524208
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	397855
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	904681
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	301048
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2201861
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1916601
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	9622279
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10100138
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	18037323
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	30000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	32500
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3597014
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3079887
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	9016140
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5520034
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	5290500
CY2023Q4	us-gaap	Liabilities Liabilities	22743292
CY2022Q4	us-gaap	Liabilities Liabilities	31960244
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26219461
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25661488
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5244
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5126
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	285713238
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	283019456
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254370827
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-209153659
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	48877
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	51924
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	31396532
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	73922847
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-3102197
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-1486179
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28294335
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	72436668
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51037627
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104396912
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6994838
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	370176
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2736998
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81295
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20119791
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20223495
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	26170221
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20130546
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3500000
CY2022	nhwk	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-3342515
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	49027010
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	40592821
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-42032172
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-40222645
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11020
CY2023	us-gaap	Interest Income Other InterestIncomeOther	457189
CY2022	us-gaap	Interest Income Other InterestIncomeOther	987247
CY2023	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	123044
CY2022	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-1701428
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-776838
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-182509
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-104822
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-482689
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-301427
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1368359
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42333599
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41591004
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-571120
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-215937
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41762479
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41375067
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-5005518
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-5560130
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	65189
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-3073000
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5070707
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2487130
CY2023	us-gaap	Profit Loss ProfitLoss	-46833186
CY2022	us-gaap	Profit Loss ProfitLoss	-43862197
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1616018
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-427491
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45217168
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43434706
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26046594
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26046594
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25606326
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25606326
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.54
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.54
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.60
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.60
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.19
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.19
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.10
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.10
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.74
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.74
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2023	us-gaap	Profit Loss ProfitLoss	-46833186
CY2022	us-gaap	Profit Loss ProfitLoss	-43862197
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3047
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	119865
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-46836233
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43742332
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1616018
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-427491
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-45220215
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43314841
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	112033571
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	43637
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	4085737
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16055
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	119865
CY2022	us-gaap	Profit Loss ProfitLoss	-43862197
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	72436668
CY2023	nhwk	Stock Issued During Period Value New Issues2 StockIssuedDuringPeriodValueNewIssues2	46142
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	19482
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2628276
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3047
CY2023	us-gaap	Profit Loss ProfitLoss	-46833186
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28294335
CY2023	us-gaap	Profit Loss ProfitLoss	-46833186
CY2022	us-gaap	Profit Loss ProfitLoss	-43862197
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3873079
CY2023	nhwk	Disposal Group Including Discontinued Operation Intangible Asset Impairment Loss DisposalGroupIncludingDiscontinuedOperationIntangibleAssetImpairmentLoss	2277921
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3500000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6474256
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2115015
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1091250
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1030625
CY2023	nhwk	Noncash Lease Expense NoncashLeaseExpense	514665
CY2022	nhwk	Noncash Lease Expense NoncashLeaseExpense	116583
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2628276
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4085737
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11020
CY2023	nhwk	Change In Fair Value Of Contingent Consideration Including Discontinued Operations ChangeInFairValueOfContingentConsiderationIncludingDiscontinuedOperations	-107355
CY2022	nhwk	Change In Fair Value Of Contingent Consideration Including Discontinued Operations ChangeInFairValueOfContingentConsiderationIncludingDiscontinuedOperations	-3452015
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	123019
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1701443
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	231633
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8952074
CY2023	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-571120
CY2022	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-3288937
CY2023	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	1073145
CY2023	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	1467451
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	293698
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15967
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	368124
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-12233529
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2731454
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-58656
CY2023	nhwk	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	-1524522
CY2022	nhwk	Increase Decrease In Grants Receivable IncreaseDecreaseInGrantsReceivable	206163
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-24526231
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	909158
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5844000
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-600877
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-443968
CY2023	nhwk	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	277807
CY2022	nhwk	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	12158238
CY2023	nhwk	Increase Decrease In Deposits Operating Activity IncreaseDecreaseInDepositsOperatingActivity	42439
CY2022	nhwk	Increase Decrease In Deposits Operating Activity IncreaseDecreaseInDepositsOperatingActivity	-64560
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-116908
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3299326
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	771133
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1583308
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1921496
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-3126158
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-53530
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31532595
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5700364
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	483497
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2457348
CY2023	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	34237270
CY2022	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	53243519
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1985557
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20117998
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	220802
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	388103
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	247577
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-2719899
CY2022	us-gaap	Payment For Contingent Consideration Liability Investing Activities PaymentForContingentConsiderationLiabilityInvestingActivities	22784571
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	32236595
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10991604
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65624
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	59692
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6434115
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4735000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2583583
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4906941
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1555
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3624
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8249629
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	380675
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8434554
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8053879
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184925
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8434554
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	895578
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6348346
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9983504
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	15477515
CY2023	nhwk	Right Of Use Asset Surrender In Exchange For Finance Lease Liability Modifications RightOfUseAssetSurrenderInExchangeForFinanceLeaseLiabilityModifications	-3092408
CY2022	nhwk	Right Of Use Asset Surrender In Exchange For Finance Lease Liability Modifications RightOfUseAssetSurrenderInExchangeForFinanceLeaseLiabilityModifications	-81752
CY2023	nhwk	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Modifications RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityModifications	70033
CY2022	nhwk	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Modifications RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityModifications	37654
CY2023	nhwk	Right Of Use Asset Obtained In Exchange For Operating Lease Liability Modifications RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityModifications	87839
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	288807
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	42853685
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	5242840
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	184925
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3191714
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	184925
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	8434554
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5032271
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	30042512
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	41854
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-20064672
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-4735000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254400000
CY2023	us-gaap	Profit Loss ProfitLoss	-46800000
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	2400000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of fixed assets, consideration receivable, other intangible assets, income taxes, stock-based compensation, right-of-use assets and lease liabilities, estimates used in divestiture accounting, and useful lives of intangible assets. Actual results may differ from those estimates.</p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At times, cash balances may exceed the Federal Deposit Insurance Corporation (“FDIC”) insurable limits. The Company has never experienced any losses related to these balances. As of December 31, 2023, there were no cash amounts in excess of $250,000. As of December 31, 2022, the uninsured balance was $7.8 million. The Company does not believe it is exposed to significant credit risk on cash and cash equivalents.</p>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	7800000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2400000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1600000
CY2023Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	100000
CY2022Q4	us-gaap	Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax	-1700000
CY2022Q4	nhwk	Assets Transfer From Level1 To Level2 Transfers Amount1 AssetsTransferFromLevel1ToLevel2TransfersAmount1	0
CY2023Q4	nhwk	Assets Transfer From Level1 To Level2 Transfers Amount1 AssetsTransferFromLevel1ToLevel2TransfersAmount1	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2023	nhwk	Change In Fair Value Of Contingent Consideration Discontinued Operations ChangeInFairValueOfContingentConsiderationDiscontinuedOperations	-100000
CY2022	nhwk	Change In Fair Value Of Contingent Consideration Discontinued Operations ChangeInFairValueOfContingentConsiderationDiscontinuedOperations	-100000
CY2022	nhwk	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-3300000
CY2023Q4	nhwk	Prepaid Manufacturing Expense PrepaidManufacturingExpense	102761
CY2022Q4	nhwk	Prepaid Manufacturing Expense PrepaidManufacturingExpense	91477
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	120184
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	476233
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1132502
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	96588
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	201252
CY2023Q4	nhwk	Prepaid Preclinical And Clinical Expenses PrepaidPreclinicalAndClinicalExpenses	21263
CY2022Q4	nhwk	Prepaid Preclinical And Clinical Expenses PrepaidPreclinicalAndClinicalExpenses	65892
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	817029
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1491123
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25168330
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23392138
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7580993
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2953617
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17587337
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20438521
CY2023	us-gaap	Depreciation Depreciation	4600000
CY2022	us-gaap	Depreciation Depreciation	1800000
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	1013497
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	313254
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	426025
CY2023Q4	nhwk	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	405792
CY2022Q4	nhwk	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	953252
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	332641
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	491191
CY2023Q4	nhwk	Accrued Manufacturing Expenses AccruedManufacturingExpenses	97877
CY2022Q4	nhwk	Accrued Manufacturing Expenses AccruedManufacturingExpenses	6133
CY2023Q4	nhwk	Accrued Franchise Tax AccruedFranchiseTax	38800
CY2022Q4	nhwk	Accrued Franchise Tax AccruedFranchiseTax	40000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2201861
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1916601
CY2023	nhwk	Process Development Revenue Recognized ProcessDevelopmentRevenueRecognized	6600000
CY2022	nhwk	Process Development Revenue Recognized ProcessDevelopmentRevenueRecognized	100000
CY2021Q4	nhwk	Process Development Contract Liability ProcessDevelopmentContractLiability	37500
CY2022	nhwk	Process Development Contract Liability Reclassification To Revenue ProcessDevelopmentContractLiabilityReclassificationToRevenue	76019
CY2022	nhwk	Process Development Contract Liability Net Change To Contract Balance ProcessDevelopmentContractLiabilityNetChangeToContractBalance	1656827
CY2022Q4	nhwk	Process Development Contract Liability ProcessDevelopmentContractLiability	1618308
CY2023	nhwk	Process Development Contract Liability Reclassification To Revenue ProcessDevelopmentContractLiabilityReclassificationToRevenue	6358617
CY2023	nhwk	Process Development Contract Liability Net Change To Contract Balance ProcessDevelopmentContractLiabilityNetChangeToContractBalance	7129750
CY2023Q4	nhwk	Process Development Contract Liability ProcessDevelopmentContractLiability	2389441
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1200000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3000.000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66049
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81456
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	375192
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26219461
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25661488
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2628276
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4085737
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.0085
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.0509
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0195
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0361
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.87
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2954315
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.62
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100419
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4307599
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.10
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12765
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.30
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	82253
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	10.20
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	130022
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.44
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7036874
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.67
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16842
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	198478
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	399465
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.88
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6438931
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9052
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4601719
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.52
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9052
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y8M12D
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000000.0
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-521420
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-215937
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-49700
CY2023	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	-571120
CY2022	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	-215937
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8620900
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8734000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-8900
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-146000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2200
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-19000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	57200
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000
CY2022	nhwk	Income Tax Reconciliation Nondeductible Expense Research And Development Expense IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentExpense	-1312000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	351500
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	192000
CY2022	nhwk	Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExecutiveCompensationAmount	9000
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-288400
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	358000
CY2023	nhwk	Income Tax Reconciliation Purchase Accounting Adjustment IncomeTaxReconciliationPurchaseAccountingAdjustment	571120
CY2022	nhwk	Income Tax Reconciliation Reserve For Loss Carryforwards Limited By Section382 IncomeTaxReconciliationReserveForLossCarryforwardsLimitedBySection382	8000
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-5300
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	65063
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8159000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	9720000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-571120
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-215937
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28914050
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24542949
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3830306
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3822392
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2799908
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2974242
CY2023Q4	nhwk	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	2951877
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	6307
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7465
CY2023Q4	nhwk	Deferred Tax Assets Amortization Of Research And Experimental Expenditures DeferredTaxAssetsAmortizationOfResearchAndExperimentalExpenditures	7481832
CY2022Q4	nhwk	Deferred Tax Assets Amortization Of Research And Experimental Expenditures DeferredTaxAssetsAmortizationOfResearchAndExperimentalExpenditures	4041814
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	319826
CY2023Q4	nhwk	Deferred Tax Assets Unrealized Gains Losses DeferredTaxAssetsUnrealizedGainsLosses	507547
CY2022Q4	nhwk	Deferred Tax Assets Unrealized Gains Losses DeferredTaxAssetsUnrealizedGainsLosses	583683
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	46811653
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	35972545
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	738290
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	553840
CY2023Q4	nhwk	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	5573944
CY2022Q4	nhwk	Deferred Tax Liabilities Lease Liability DeferredTaxLiabilitiesLeaseLiability	2732712
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	99272
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6312234
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3385824
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40499419
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32586721
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	40500000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32600000
CY2021	nhwk	Number Of Ownership Changes Over Fifty Percent NumberOfOwnershipChangesOverFiftyPercent	5
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1480974000
CY2023	nhwk	Unrecognized Tax Benefits Decrease Resulting From Disposition UnrecognizedTaxBenefitsDecreaseResultingFromDisposition	1480974000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	800000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	800000
CY2023	nhwk	Right Of Use Assets Obtained Through Additional Finance Equipment Leases RightOfUseAssetsObtainedThroughAdditionalFinanceEquipmentLeases	2200000
CY2023	nhwk	Right Of Use Asset Obtained In Exchange For Finance Lease Liability Modifications RightOfUseAssetObtainedInExchangeForFinanceLeaseLiabilityModifications	70000.00
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1239539
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	732767
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1816463
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	656794
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	776838
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	181667
CY2023	us-gaap	Lease Cost LeaseCost	2593301
CY2022	us-gaap	Lease Cost LeaseCost	838461
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0967
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0937
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1011
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0960
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	892779
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1854104
CY2023Q4	nhwk	Lease Liability To Be Paid Year One LeaseLiabilityToBePaidYearOne	2746883
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	878281
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1765385
CY2023Q4	nhwk	Lease Liability To Be Paid Year Two LeaseLiabilityToBePaidYearTwo	2643666
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	828175
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1679279
CY2023Q4	nhwk	Lease Liability To Be Paid Year Three LeaseLiabilityToBePaidYearThree	2507454
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	855510
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	902127
CY2023Q4	nhwk	Lease Liability To Be Paid Year Four LeaseLiabilityToBePaidYearFour	1757637
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	883863
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	931290
CY2023Q4	nhwk	Lease Liability To Be Paid Year Five LeaseLiabilityToBePaidYearFive	1815153
CY2023Q4	nhwk	Lessee Operating Lease Liability To Be Paid Year Six LesseeOperatingLeaseLiabilityToBePaidYearSix	652422
CY2023Q4	nhwk	Finance Lease Liability To Be Paid Year Six FinanceLeaseLiabilityToBePaidYearSix	961311
CY2023Q4	nhwk	Lease Liability To Be Paid Year Six LeaseLiabilityToBePaidYearSix	1613733
CY2023Q4	nhwk	Lessee Operating Lease Liability To Be Paid Year Seven LesseeOperatingLeaseLiabilityToBePaidYearSeven	536932
CY2023Q4	nhwk	Finance Lease Liability To Be Paid Year Seven FinanceLeaseLiabilityToBePaidYearSeven	1062262
CY2023Q4	nhwk	Lease Liability To Be Paid Year Seven LeaseLiabilityToBePaidYearSeven	1599194
CY2023Q4	nhwk	Finance Lease Liability To Be Paid After Year Seven FinanceLeaseLiabilityToBePaidAfterYearSeven	8278092
CY2023Q4	nhwk	Lease Liability To Be Paid After Year Seven LeaseLiabilityToBePaidAfterYearSeven	8278092
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5527962
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	17433850
CY2023Q4	nhwk	Lease Liability Payment Due LeaseLiabilityPaymentDue	22961812
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1406740
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	7513029
CY2023Q4	nhwk	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	8919769
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4121222
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	9920821
CY2023Q4	nhwk	Lease Liability LeaseLiability	14042043
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41762479
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-41375067
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5070707
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2487130
CY2023	us-gaap	Profit Loss ProfitLoss	-46833186
CY2022	us-gaap	Profit Loss ProfitLoss	-43862197
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1616018
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-427491
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-45217168
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-43434706
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26046594
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26046594
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25606326
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25606326
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.54
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.60
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.19
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.10
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.74
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70

Files In Submission

Name	View Source	Status
0001558370-24-005902-index-headers.html	Edgar Link	pending
0001558370-24-005902-index.html	Edgar Link	pending
0001558370-24-005902.txt	Edgar Link	pending
0001558370-24-005902-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scpx-20231231.xsd	Edgar Link	pending
scpx-20231231x10k.htm	Edgar Link	pending
scpx-20231231xex21d1.htm	Edgar Link	pending
scpx-20231231xex21d1001.jpg	Edgar Link	pending
scpx-20231231xex21d1002.jpg	Edgar Link	pending
scpx-20231231xex23d1.htm	Edgar Link	pending
scpx-20231231xex31d1.htm	Edgar Link	pending
scpx-20231231xex31d2.htm	Edgar Link	pending
scpx-20231231xex32d1.htm	Edgar Link	pending
scpx-20231231xex32d2.htm	Edgar Link	pending
scpx-20231231xex4d14.htm	Edgar Link	pending
scpx-20231231xex97d1.htm	Edgar Link	pending
scpx-20231231xex97d1001.jpg	Edgar Link	pending
scpx-20231231xex97d1002.jpg	Edgar Link	pending
scpx-20231231xex97d1003.jpg	Edgar Link	pending
scpx-20231231xex97d1004.jpg	Edgar Link	pending
scpx-20231231xex97d1005.jpg	Edgar Link	pending
scpx-20231231xex97d1006.jpg	Edgar Link	pending
scpx-20231231xex97d1007.jpg	Edgar Link	pending
scpx-20231231xex97d1008.jpg	Edgar Link	pending
scpx-20231231xex97d1011.jpg	Edgar Link	pending
scpx-20231231xex97d1012.jpg	Edgar Link	pending
scpx-20231231xex97d1013.jpg	Edgar Link	pending
scpx-20231231xex97d1014.jpg	Edgar Link	pending
scpx-20231231xex97d1015.jpg	Edgar Link	pending
scpx-20231231xex97d1016.jpg	Edgar Link	pending
scpx-20231231xex97d1017.jpg	Edgar Link	pending
scpx-20231231xex97d1018.jpg	Edgar Link	pending
scpx-20231231xex97d1019.jpg	Edgar Link	pending
scpx-20231231xex97d1021.jpg	Edgar Link	pending
scpx-20231231xex97d1022.jpg	Edgar Link	pending
scpx-20231231xex97d1023.jpg	Edgar Link	pending
scpx-20231231xex97d1024.jpg	Edgar Link	pending
scpx-20231231xex97d1027.jpg	Edgar Link	pending
scpx-20231231xex97d1028.jpg	Edgar Link	pending
scpx-20231231xex97d1029.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
scpx-20231231_def.xml	Edgar Link	unprocessable
scpx-20231231_lab.xml	Edgar Link	unprocessable
scpx-20231231_pre.xml	Edgar Link	unprocessable
scpx-20231231_cal.xml	Edgar Link	unprocessable
scpx-20231231x10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2024 Q2 Form 10-K Financial Statement

#000155837024005902 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2024 Q2 Form 10-K Financial Statement

#000155837024005902 Filed on April 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx